267 filings
Page 5 of 14
D
ilfx4fzrtnd1auvfqpz
29 Apr 22
$19.5M in equity / options, sold $19.5M, 9 investors
2:13pm
8-K
8bc7a4lwqn2 1uat2wk
28 Apr 22
Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market
5:03pm
EFFECT
l61xeius740ki
11 Apr 22
Notice of effectiveness
12:15am
8-K
7fdo 3h1z
8 Apr 22
Departure of Directors or Certain Officers
4:05pm
424B3
h566 y9zqmpyj6n
8 Apr 22
Prospectus supplement
9:10am
UPLOAD
omv41m2vk2zj78k
7 Apr 22
Letter from SEC
12:00am
CORRESP
o85 yr6r0
7 Apr 22
Correspondence with SEC
12:00am
S-3
j8ssmwh4b zn
30 Mar 22
Shelf registration
5:20pm
8-K
15uy46 wf4
24 Mar 22
Other Events
4:15pm
D
i3c 51yfe1830lp74hy
18 Mar 22
$8M in equity / options, sold $8M, 9 investors
7:58am
8-K
0gs1gn14hoz gbec
14 Mar 22
Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-Market
6:42pm
8-K
vtfuhc6n0kx
25 Feb 22
Sunshine Biopharma Expands Anti-coronavirus Drug Development Program by Signing a Collaboration Agreement with the University of Arizona
8:00am
8-K
bju5jv9iw
17 Feb 22
Sunshine Biopharma, Inc. Announces Pricing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market
10:25am
424B4
xp1fjfg9od92
17 Feb 22
Prospectus supplement with pricing info
6:00am
EFFECT
s82s7zk
15 Feb 22
Notice of effectiveness
12:15am
CERT
b6m5s0rmce 9m15ckoe
11 Feb 22
Certification of approval for exchange listing
12:00am